✦ LIBER ✦

Is inactivation of O 6 -methylguanine DNA methyltransferase still a favorable prognostic factor of patients with diffuse large B-cell lymphoma in the era of R-CHOP chemotherapy?

✍ Scribed by Lee, Gyeong-Won; Kang, Jung-Hun; Kim, In-Suk; Kim, Hoon-Gu; Ko, Gyung Hyuck; Lee, Jeong Hee; Kim, Dong Chool; Song, Dae Hyun; Yang, Jung Wook; Lee, Jong Sil

Book ID: 119968843
Publisher: Informa plc
Year: 2009
Tongue: English
Weight: 556 KB
Volume: 50
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428190903312462

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic significance of O6-methylguan

Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas

✍ SUN MI LEE; EUI JIN LEE; YOUNG-HYEH KO; SUG HYUNG LEE; LEESO MAENG; KYOUNG-MEE K 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

High frequency and strong prognostic rel

High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East

✍ Khawla Al-Kuraya; Rajeswari Narayanappa; Abdul Khalid Siraj; Fouad Al-Dayel; Adn 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 569 KB

Reassessment of the prognostic factors o

Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population

✍ Shen Yang; Yao Yu; Li Jun-Min; Mi Jian-Qing; Chen Qiu-Sheng; Chen Yu; Zhao Wei-L 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 144 KB

An enhanced International Prognostic Ind

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

✍ Zhou, Z.; Sehn, L. H.; Rademaker, A. W.; Gordon, L. I.; LaCasce, A. S.; Crosby-T 📂 Article 📅 2014 🏛 American Society of Hematology 🌐 English ⚖ 528 KB

Activation of the STAT3 Signaling Pathwa

Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

✍ Huang, X.; Meng, B.; Iqbal, J.; Ding, B. B.; Perry, A. M.; Cao, W.; Smith, L. M. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 664 KB

Brief-Duration Rituximab/Chemotherapy Fo

Brief-Duration Rituximab/Chemotherapy Followed by Maintenance Rituximab in Patients With Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

✍ John D. Hainsworth; Ian W. Flinn; David R. Spigel; Bobby L. Clark; Paula L. Grin 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 131 KB